These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The role of the amyloid protein precursor (APP) in Alzheimer's disease: does the normal function of APP explain the topography of neurodegeneration? Small DH Neurochem Res; 1998 May; 23(5):795-806. PubMed ID: 9566620 [TBL] [Abstract][Full Text] [Related]
26. Recent advances in the genetics of Alzheimer's disease. Levy-Lahad E; Tsuang D; Bird TD J Geriatr Psychiatry Neurol; 1998; 11(2):42-54. PubMed ID: 9877525 [TBL] [Abstract][Full Text] [Related]
27. Association studies testing for risk for late-onset Alzheimer's disease with common variants in the beta-amyloid precursor protein (APP). Nowotny P; Simcock X; Bertelsen S; Hinrichs AL; Kauwe JS; Mayo K; Smemo S; Morris JC; Goate A Am J Med Genet B Neuropsychiatr Genet; 2007 Jun; 144B(4):469-74. PubMed ID: 17427190 [TBL] [Abstract][Full Text] [Related]
28. Screening for mutations in the open reading frame and promoter of the beta-amyloid precursor protein gene in familial Alzheimer's disease: identification of a further family with APP717 Val-->Ile. Fidani L; Rooke K; Chartier-Harlin MC; Hughes D; Tanzi R; Mullan M; Roques P; Rossor M; Hardy J; Goate A Hum Mol Genet; 1992 Jun; 1(3):165-8. PubMed ID: 1303172 [TBL] [Abstract][Full Text] [Related]
30. Molecular genetics of Alzheimer's disease: what have we learned? Van Gassen G; Van Broeckhoven C Acta Neurol Belg; 2000 Jun; 100(2):65-76. PubMed ID: 10934557 [TBL] [Abstract][Full Text] [Related]
31. Genetic risk and transcriptional variability of amyloid precursor protein in Alzheimer's disease. Brouwers N; Sleegers K; Engelborghs S; Bogaerts V; Serneels S; Kamali K; Corsmit E; De Leenheir E; Martin JJ; De Deyn PP; Van Broeckhoven C; Theuns J Brain; 2006 Nov; 129(Pt 11):2984-91. PubMed ID: 16931535 [TBL] [Abstract][Full Text] [Related]
32. Heterogeneity in Alzheimer's disease. Hardy J; Duff K Ann Med; 1993 Oct; 25(5):437-40. PubMed ID: 8251141 [TBL] [Abstract][Full Text] [Related]
33. ApoE genotype and familial Alzheimer's disease: a possible influence on age of onset in APP717 Val-->Ile mutated families. Nacmias B; Latorraca S; Piersanti P; Forleo P; Piacentini S; Bracco L; Amaducci L; Sorbi S Neurosci Lett; 1995 Jan; 183(1-2):1-3. PubMed ID: 7746463 [TBL] [Abstract][Full Text] [Related]
34. The human β-amyloid precursor protein: biomolecular and epigenetic aspects. Nguyen KV Biomol Concepts; 2015 Mar; 6(1):11-32. PubMed ID: 25719338 [TBL] [Abstract][Full Text] [Related]
35. APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy. Sleegers K; Brouwers N; Gijselinck I; Theuns J; Goossens D; Wauters J; Del-Favero J; Cruts M; van Duijn CM; Van Broeckhoven C Brain; 2006 Nov; 129(Pt 11):2977-83. PubMed ID: 16921174 [TBL] [Abstract][Full Text] [Related]
37. [Genetic factors and a polygenic model of Alzheimer's disease]. Rogaev EI Genetika; 1999 Nov; 35(11):1558-71. PubMed ID: 10624576 [TBL] [Abstract][Full Text] [Related]
39. Sequencing of exons 16 and 17 of the beta-amyloid precursor protein gene in 14 families with early onset Alzheimer's disease fails to reveal mutations in the beta-amyloid sequence. Crawford F; Hardy J; Mullan M; Goate A; Hughes D; Fidani L; Roques P; Rossor M; Chartier-Harlin MC Neurosci Lett; 1991 Nov; 133(1):1-2. PubMed ID: 1791986 [TBL] [Abstract][Full Text] [Related]
40. A mutation protective against Alzheimer's disease renders amyloid β precursor protein incapable of mediating neurotoxicity. Hashimoto Y; Matsuoka M J Neurochem; 2014 Jul; 130(2):291-300. PubMed ID: 24646423 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]